Tisch Multiple Sclerosis Research Center Of New York

Researchers are providing an experimental treatment to people with progressive multiple sclerosis who cannot join a separate Phase II stem cell trial. The treatment uses the patient's own bone marrow cells, which are grown in the lab into neural progenitor cells and then injected…